University of California, Los Angeles /ID# 155429 — Los Angeles, California

University of California, Los Angeles /ID# 155429 is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

University of California, Los Angeles /ID# 155429 has participated in 1 clinical trials.

Therapeutic areas: Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California, Los Angeles /ID# 155429?

University of California, Los Angeles /ID# 155429 has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California, Los Angeles /ID# 155429 conducted?

University of California, Los Angeles /ID# 155429 has 1 clinical trials on record. Their work covers Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma.

Is University of California, Los Angeles /ID# 155429 accredited by Crixeo Health?

University of California, Los Angeles /ID# 155429 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California, Los Angeles /ID# 155429?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.